|
1
|
Nakagawa H, Fujita M and Fujimoto A:
Genome sequencing analysis of liver cancer for precision medicine.
Semin Cancer Biol. Mar 29–2018;(Epub ahead of print). PubMed/NCBI
|
|
2
|
Sia D, Villanueva A, Friedman SL and
Llovet JM: Liver cancer cell of origin, molecular class, and
effects on patient prognosis. Gastroenterology. 152:745–761. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Karimi M, Ghasemi A, Sahandi Zangabad P,
Rahighi R, Moosavi Basri SM, Mirshekari H, Amiri M, Shafaei
Pishabad Z, Aslani A, Bozorgomid M, et al: Smart
micro/nanoparticles in stimulus-responsive drug/gene delivery
systems. Chem Soc Rev. 45:1457–1501. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cervello M, Pitarresi G, Volpe AB, Porsio
B, Balasus D, Emma MR, Azzolina A, Puleio R, Loria GR, Puleo S and
Giammona G: Nanoparticles of a polyaspartamide-based brush
copolymer for modified release of sorafenib: In vitro and in vivo
evaluation. J Control Release. 266:47–56. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lin Q, Bao C, Yang Y, Liang Q, Zhang D,
Cheng S and Zhu L: Highly discriminating photorelease of anticancer
drugs based on hypoxia activatable phototrigger conjugated chitosan
nanoparticles. Adv Mater. 25:1981–1986. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Castro F, Pinto ML, Silva AM, Pereira CL,
Teixeira GQ, Gomez-Lazaro M, Santos SG, Barbosa MA, Gonçalves RM
and Oliveira MJ: Pro-inflammatory chitosan/poly(gamma-glutamic
acid) nanoparticles modulate human antigen-presenting cells
phenotype and revert their pro-invasive capacity. Acta Biomater.
63:96–109. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liang X, Fang L, Li X, Zhang X and Wang F:
Activatable near infrared dye conjugated hyaluronic acid based
nanoparticles as a targeted theranostic agent for enhanced
fluorescence/CT/photoacoustic imaging guided photothermal therapy.
Biomaterials. 132:72–84. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu JL, Tian GX, Yu WJ, Jia GT, Sun TY and
Gao ZQ: pH-Responsive Hyaluronic Acid-Based Mixed Micelles for the
Hepatoma-Targeting Delivery of Doxorubicin. Int J Mol Sci.
17:3642016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sui J, Cui Y, Cai H, Bian S, Xu Z, Zhou L,
Sun Y, Liang J, Fan Y and Zhang X: Synergistic chemotherapeutic
effect of sorafenib-loaded pullulan-Dox conjugate nanoparticles
against murine breast carcinoma. Nanoscale. 9:2755–2767. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tamura R, Uemoto S and Tabata Y: Augmented
liver targeting of exosomes by surface modification with cationized
pullulan. Acta Biomater. 57:274–284. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xiong H, Du S, Ni J, Zhou J and Yao J:
Mitochondria and nuclei dual-targeted heterogeneous hydroxyapatite
nanoparticles for enhancing therapeutic efficacy of doxorubicin.
Biomaterials. 94:70–83. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li K, Liu H, Gao W, Chen M, Zeng Y, Liu J,
Xu L and Wu D: Mulberry-like dual-drug complicated nanocarriers
assembled with apogossypolone amphiphilic starch micelles and
doxorubicin hyaluronic acid nanoparticles for tumor combination and
targeted therapy. Biomaterials. 39:131–144. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Han X, Dong X, Li J, Wang M, Luo L, Li Z,
Lu X, He R, Xu R and Gong M: Free paclitaxel-loaded E-selectin
binding peptide modified micelle self-assembled from hyaluronic
acid-paclitaxel conjugate inhibit breast cancer metastasis in a
murine model. Int J Pharm. 528:33–46. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang H, Li W, Guo X, Kong F, Wang Z, Zhu
C, Luo L, Li Q, Yang J, Du Y and You J: Specifically increased
paclitaxel release in tumor and synergetic therapy by a hyaluronic
acid-tocopherol nanomicelle. ACS Appl Mater Interfaces.
9:20385–20398. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lin L, Cai M, Deng S, Huang W, Huang J,
Huang X, Huang M, Wang Y, Shuai X and Zhu K: Amelioration of
cirrhotic portal hypertension by targeted cyclooxygenase-1 siRNA
delivery to liver sinusoidal endothelium with polyethylenimine
grafted hyaluronic acid. Nanomedicine. 13:2329–2339. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou Z, Li H, Wang K, Guo Q, Li C, Jiang
H, Hu Y, Oupicky D and Sun M: Bioreducible cross-linked hyaluronic
acid/calcium phosphate hybrid nanoparticles for specific delivery
of siRNA in melanoma tumor therapy. ACS Appl Mater Interfaces.
9:14576–14589. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fan J and Yang J: Preparation and
characterization of a chitosan/galactosylated hyaluronic
acid/heparin scaffold for hepatic tissue engineering. J Biomater
Sci Polym Ed. 28:569–581. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Han X, Wang Z, Wang M, Li J, Xu Y, He R,
Guan H, Yue Z and Gong M: Liver-targeting self-assembled hyaluronic
acid-glycyrrhetinic acid micelles enhance hepato-protective effect
of silybin after oral administration. Drug Deliv. 23:1818–1829.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang L, Yao J, Zhou J, Wang T and Zhang
Q: Glycyrrhetinic acid-graft-hyaluronic acid conjugate as a carrier
for synergistic targeted delivery of antitumor drugs. Int J Pharm.
441:654–664. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang X, Gu X, Wang H, Sun Y, Wu H and Mao
S: Synthesis, characterization and liver targeting evaluation of
self-assembled hyaluronic acid nanoparticles functionalized with
glycyrrhetinic acid. Eur J Pharm Sci. 96:255–262. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dahlman JE, Kauffman KJ, Xing Y, Shaw TE,
Mir FF, Dlott CC, Langer R, Anderson DG and Wang ET: Barcoded
nanoparticles for high throughput in vivo discovery of targeted
therapeutics. Proc Natl Acad Sci USA. 114:2060–2065. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li J, Chen T, Deng F, Wan J, Tang Y, Yuan
P and Zhang L: Synthesis, characterization, and in vitro evaluation
of curcumin-loaded albumin nanoparticles surface-functionalized
with glycyrrhetinic acid. Int J Nanomedicine. 10:5475–5487.
2015.PubMed/NCBI
|
|
23
|
Lv Y, Li J, Chen H, Bai Y and Zhang L:
Glycyrrhetinic acid-functionalized mesoporous silica nanoparticles
as hepatocellular carcinoma-targeted drug carrier. Int J
Nanomedicine. 12:4361–4370. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Qi WW, Yu HY, Guo H, Lou J, Wang ZM, Liu
P, Sapin-Minet A, Maincent P, Hong XC, Hu XM and Xiao YL:
Doxorubicin-loaded glycyrrhetinic acid modified recombinant human
serum albumin nanoparticles for targeting liver tumor chemotherapy.
Mol Pharm. 12:675–683. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Spaeth JR, Kevrekidis IG and
Panagiotopoulos AZ: A comparison of implicit- and explicit-solvent
simulations of self-assembly in block copolymer and solute systems.
J Chem Phys. 134:1649022011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Park K, Lee GY, Kim YS, Yu M, Park RW, Kim
IS, Kim SY and Byun Y: Heparin-deoxycholic acid chemical conjugate
as an anticancer drug carrier and its antitumor activity. J Control
Release. 114:300–306. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huang W, Wang W, Wang P, Tian Q, Zhang C,
Wang C, Yuan Z, Liu M, Wan H and Tang H: Glycyrrhetinic
acid-modified poly(ethylene glycol)-b-poly(gamma-benzyl
l-glutamate) micelles for liver targeting therapy. Acta Biomater.
6:3927–3935. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wu JL, Liu CG, Wang XL and Huang ZH:
Preparation and characterization of nanoparticles based on
histidine-hyaluronic acid conjugates as doxorubicin carriers. J
Mater Sci Mater Med. 23:1921–1929. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang C, Wang W, Liu T, Wu Y, Guo H, Wang
P, Tian Q, Wang Y and Yuan Z: Doxorubicin-loaded glycyrrhetinic
acid-modified alginate nanoparticles for liver tumor chemotherapy.
Biomaterials. 33:2187–2196. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen H, Li M, Wan T, Zheng Q, Cheng M,
Huang S and Wang Y: Design and synthesis of dual-ligand modified
chitosan as a liver targeting vector. J Mater Sci Mater Med.
23:431–441. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lee H, Mok H, Lee S, Oh YK and Park TG:
Target-specific intracellular delivery of siRNA using degradable
hyaluronic acid nanogels. J Control Release. 119:245–252. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Choi KY, Chung H, Min KH, Yoon HY, Kim K,
Park JH, Kwon IC and Jeong SY: Self-assembled hyaluronic acid
nanoparticles for active tumor targeting. Biomaterials. 31:106–114.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Qiu L, Li Z, Qiao M, Long M, Wang M, Zhang
X, Tian C and Chen D: Self-assembled pH-responsive hyaluronic
acid-g-poly((L)-histidine) copolymer micelles for targeted
intracellular delivery of doxorubicin. Acta Biomater. 10:2024–2035.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bastakoti BP, Liao SH, Inoue M, Yusa SI,
Imura M, Nakashima K, Wu KC and Yamauchi Y: pH-responsive polymeric
micelles with core-shell-corona architectures as intracellular
anti-cancer drug carriers. Sci Technol Adv Mater. 14:0444022013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Luo Z and Jiang J: pH-sensitive drug
loading/releasing in amphiphilic copolymer PAE-PEG: Integrating
molecular dynamics and dissipative particle dynamics simulations. J
Control Release. 162:185–193. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Qiu L, Qiao M, Chen Q, Tian C, Long M,
Wang M, Li Z, Hu W, Li G, Cheng L, et al: Enhanced effect of
pH-sensitive mixed copolymer micelles for overcoming multidrug
resistance of doxorubicin. Biomaterials. 35:9877–9887. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Du H, Liu M, Yu A, Ji J and Zhai G:
Insight into the role of dual-ligand modification in low molecular
weight heparin based nanocarrier for targeted delivery of
doxorubicin. Int J Pharm. 523:427–438. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Di Y, Li T, Zhu Z, Chen F, Jia L, Liu W,
Gai X, Wang Y, Pan W and Yang X: pH-sensitive and folic
acid-targeted MPEG-PHIS/FA-PEG-VE mixed micelles for the delivery
of PTX-VE and their antitumor activity. Int J Nanomedicine.
12:5863–5877. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kobayashi T, Ishida T, Okada Y, Ise S,
Harashima H and Kiwada H: Effect of transferrin receptor-targeted
liposomal doxorubicin in P-glycoprotein-mediated drug resistant
tumor cells. Int J Pharm. 329:94–102. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Iyer AK, Khaled G, Fang J and Maeda H:
Exploiting the enhanced permeability and retention effect for tumor
targeting. Drug Discov Today. 11:812–818. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Björnmalm M, Thurecht KJ, Michael M, Scott
AM and Caruso F: Bridging Bio-Nano Science and Cancer Nanomedicine.
ACS Nano. 11:9594–9613. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang J, Ma W, Guo Q, Li Y, Hu Z, Zhu Z,
Wang X, Zhao Y, Chai X and Tu P: The effect of dual-functional
hyaluronic acid-vitamin E succinate micelles on targeting delivery
of doxorubicin. Int J Nanomedicine. 11:5851–5870. 2016. View Article : Google Scholar : PubMed/NCBI
|
